Table 3

Latest dose and interval of rituximab treatment at study end

Final doseNumber of participantsFinal interval, months, median (IQR)
1000 mg37 (29%)*6.4 (6.0–9.7)
500 mg51 (40%)*6.2 (6.0–7.8)
200 mg38 (30%)*6.0 (5.7–6.9)
  • *Percentages do not sum to 100% because of rounding.